Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention

Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes

(2020) Maurizio Menichelli et al.   ANNALS OF INTERNAL MEDICINE

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry

(2020) Sebastian Völz et al.   Journal of the American Heart Association

Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial

(2020) George J. Vlachojannis et al.   CIRCULATION

The ‘Ten Commandments’ for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2020) Jean-Philippe Collet et al.   EUROPEAN HEART JOURNAL

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus

(2020) Gjin Ndrepepa et al.   JACC-Cardiovascular Interventions

Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome

(2020) Giuseppe Tarantini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes

(2020) Christian Dworeck et al.   JAMA Network Open

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

(2019) Stefanie Schüpke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study

(2019) Boris Schnorbus et al.   EUROPEAN HEART JOURNAL

Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers

(2018) Sara Ariotti et al.   JACC-Cardiovascular Interventions

2018 ESC/EACTS Guidelines on myocardial revascularization

(2018) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial

(2017) Christina L. Fanola et al.   Journal of the American Heart Association

Unknown

(2016)   Cardiovascular Therapeutics

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

(2014) D. Lindholm et al.   EUROPEAN HEART JOURNAL

Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI

(2014) Gilles Montalescot et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial

(2013) Stefanie Schulz et al.   Journal of Cardiovascular Translational Research

Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans

(2009) Nagy A. Farid et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

(2009) Gilles Montalescot et al.   LANCET

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE